| Field | Specification |
|---|---|
| Mfr No | |
| Expression System | |
| Form | Lyophilized |
| Product Type | |
| Storage | |
| Target |
Scientific Background
Staphylococcus aureus is a leading cause of community- and hospital-acquired infections worldwide. Together, capsular polysaccharide serotypes 5 (CP5) and 8 (CP8) account for surface polysaccharide expression in approximately 80% of clinical bloodstream isolates. CP8 is a linear polysaccharide with trisaccharide repeating units that differ from CP5 in the anomeric configuration of the N-acetyl-fucosamine residue. Serotype 8 strains, including Reynolds and O13, are prevalent among nosocomial and community-acquired bacteremia cases. CP8 is a clinically important vaccine antigen candidate and a reference reagent for serotype 8-specific OPA assays and anti-S. aureus antibody quantification.
Product Description
Staphylococcus
This S. aureus Purified CP8 is a high molecular weight (Kav = 0.026) capsular polysaccharide purified from S. aureus strains Reynolds and O13. Supplied lyophilized in sterile water. Quality verified by CP8-specific monoclonal antibody 5A6.
Product Specifications
| Catalog Number | 0581-PP-002 |
|---|---|
| Full Name | Staphylococcus aureus serotype 8 capsular polysaccharide (CP8) |
| Abbreviation | CP8 |
| Target | Staphylococcus aureus Serotype 8 Capsular Polysaccharide |
| Source Strain | S. aureus Reynolds and O13 |
| Molecular Size | High molecular weight (Kav = 0.026) |
| Purity | <1% protein; <1% nucleic acid; <1% phosphorus |
| QC Method | CP8-specific monoclonal antibody 5A6 (Western Blot); ELISA inhibition with CP8-specific rabbit antiserum |
| Product Category | Staphylococcus |
| Formulation | Lyophilized in sterile water |
| Form | Lyophilized |
| Applications | ELISA, Western Blot |
| Storage | -20°C |
Safety & Handling
Related Products
Explore additional IBT Bioservices Staphylococcus aureus antigens available through BioHippo, including S. aureus Purified CP5 (BHP20900071) and recombinant S. aureus toxin proteins.
CP8 is used as a reference antigen in opsonophagocytic activity (OPA) assays, ELISA development, and serology for evaluating anti-S. aureus immune responses. It is also used as a vaccine antigen in S. aureus vaccine research.
CP5 and CP8 are structurally related but serologically distinct capsular polysaccharides from S. aureus. They differ in the anomeric configuration of the N-acetyl-fucosamine residues (C4-linked in CP5 vs. C3-linked in CP8). CP5 has a Kav of 0.038 while CP8 has a Kav of 0.026, reflecting their different molecular weight profiles. Antibodies against one serotype do not cross-react with the other, making it essential to include both serotypes in comprehensive S. aureus serology panels.
This CP8 product is purified from S. aureus strains Reynolds and O13 — two reference strains that are widely used in S. aureus serotype 8 research and OPA assay development. Quality is confirmed using the CP8-specific monoclonal antibody 5A6.
Store at -20°C for short-term use. For long-term storage, keep at -80°C. Avoid repeated freeze-thaw cycles. Aliquot into single-use volumes upon receipt to preserve product integrity.
Need a different pack size, a bulk volume, or a custom format of this product? BioHippo works directly with the manufacturer to support custom and large-volume requests. Contact us for a quote or to discuss your project requirements.
Looking for related antigens, antibodies, or matched detection kits? Contact BioHippo support and we will help identify suitable complementary products from our catalog.